Skip to main content

Ally Bridge Group — Portfolio, Page 2

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

48
Companies
$4.0B
Total invested
$94.8M
Avg. check
24
Industries
Health Care 20Biotechnology 17Therapeutics 7Oncology 6Medical 5Medical Device 5+18 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 2548 of 48
Perspective Therapeutics
February 2026

Perspective Therapeutics focuses on advancing cancer treatments employing radiation, radiopharmaceuticals, and imaging technology.

Health Care · Seattle$175.0M Post Ipo Equity
Kandu Health
January 2026

Kandu Health is a tech-enabled healthcare company that provides stroke recovery training, stroke detection research, and education services.

Education · CampbellSeries Unknown
Biobeat
December 2025

Biobeat is a med-tech company that develops remote patient monitoring and data collection tool.

Biotechnology · Boca Raton$50.0M Series B
Kestra Medical Technologies, Inc.
December 2025

Kestra Medical Technologies offers wearable medical devices which collects, store, and communicate patients vital performance data.

Health Care · Kirkland$138.0M Post Ipo Equity
MindMed
October 2025

MindMed provides psychedelic-inspired medicines and therapies for substance abuse disorders and other mental illnesses.

Biotechnology · New York$225.0M Post Ipo Equity
Mission Bio
August 2025

Mission Bio develops only single-cell multi-omics platform integrating genotype and phenotype for cancer research and biomarker development.

Bioinformatics · San FranciscoSeries Unknown
Transcarent
April 2025

Transcarent is a provider of a healthcare platform that facilitates improved outcomes and cost-effective decisions.

Health Care · San Francisco$481.0M Series D
Epicrispr Biotechnologies
March 2025

Epic Bio's strength is a relentless focus on ushering in a new era of gene regulation.

Biotechnology · South San Francisco$68.0M Series B
VitalConnect
February 2025

VitalConnect offers wearable biosensor technology for wireless patient monitoring in both hospital and remote patient populations.

Biotechnology · San Jose$100.0M Series Unknown
Tectonic Therapeutic
February 2025

Tectonic Therapeutic is a biotechnology company which focuses on scientific research in biochemistry and molecular pharmacology.

Biotechnology · Watertown$185.0M Post Ipo Equity
Aerin Medical
January 2025

Aerin Medical is a health technology company that develops therapeutic devices to improve nasal breathing.

Biotechnology · Mountain View$32.5M Undisclosed
Ultivue
July 2024

Ultivue is a biotechnology company that specializes in tissue imaging, diagnostics, and multiplexing.

Biopharma · Cambridge$3.3M Series Unknown
Context Therapeutics
May 2024

Context Therapeutics is a clinical-stage biopharmaceutical company.

Biotechnology · Philadelphia$100.0M Post Ipo Equity
Skye Bioscience
January 2024

Skye Bioscience is a pharmaceutical company developing new therapeutic outcomes for diseases.

Biotechnology · San Diego$50.3M Post Ipo Equity
Synlogic
September 2023

Synlogic is a biotechnology company that develops synthetic biotic medicines to perform metabolic functions to treat diseases.

Biotechnology · Cambridge$21.0M Post Ipo Equity
Lightforce Orthodontics
August 2023

Lightforce Orthodontics is a fully customized 3D-printed bracket system developer based on the anatomy and tooth morphology of each patient.

3D Printing · Burlington$80.0M Series D
Aeglea BioTherapeutics
June 2023

Aeglea BioTherapeutics is a clinical-stage biotechnology company that develops enzyme therapies for rare metabolic diseases.

Biotechnology · Austin$210.0M Post Ipo Equity
MedAvail
March 2023

MedAvail focuses on the discovery, development, and commercialization of advanced nutrition products.

Biotechnology · Mississauga$16.0M Post Ipo Equity
Chinook Therapeutics
May 2022

Chinook Therapeutics is a biotechnology company that specializes in the fields of therapeutics and life science.

Biotechnology · Vancouver$105.0M Post Ipo Equity
GenFleet Therapeutics
December 2021

GenFleet Therapeutics is a biotechnology developer and researcher of molecular pharmaceuticals targeting cancer treatments.

Biotechnology · Shanghai$78.7M Series C
Quantum Surgical
October 2021

Quantum Surgical mission is to democratize minimally invasive liver cancer treatment

Health Care · Montpellier$46.5M Series Unknown
Hummingbird Bioscience
May 2021

Hummingbird Bioscience focuses on the discovery and early development of oncology drugs.

Biotechnology · Woodlands$125.0M Series C
LinkDoc Technology
March 2021

LinkDoc Technology Limited is a leading oncology big data company, based in Beijing, China.

Big Data · BeijingSeries Unknown
TESARO
June 2016

TESARO is an oncology-focused biopharmaceutical company identifying better cancer therapies to improve the lives of patients with cancer.

Biopharma · Waltham$409.0M Post Ipo Equity

Where Ally Bridge Group invests

Health Care20
Biotechnology17
Therapeutics7
Oncology6
Medical5
Medical Device5

About Ally Bridge Group's portfolio

How many companies has Ally Bridge Group invested in?

Ally Bridge Group has invested in 48 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Ally Bridge Group invest in?

Ally Bridge Group's top investment sectors include Health Care, Biotechnology, Therapeutics, Oncology, Medical. The firm invests across 24 different industry categories.

What is Ally Bridge Group's largest investment?

Among tracked funding rounds, Transcarent received $481.0M in a Series D round. Ally Bridge Group's total known invested capital is $4.0B.

What is the average investment size for Ally Bridge Group?

Ally Bridge Group's average investment size is $94.8M across its portfolio of 48 companies.

What are Ally Bridge Group's most recent investments?

Recent Ally Bridge Group portfolio additions include Perspective Therapeutics, Kandu Health, Biobeat, Kestra Medical Technologies, Inc., MindMed. These companies were founded in 2020 or later.

Reach the founders behind these 48 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →